J. Kosmidis

1.2k total citations
47 papers, 794 citations indexed

About

J. Kosmidis is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, J. Kosmidis has authored 47 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 24 papers in Pharmacology and 17 papers in Molecular Medicine. Recurrent topics in J. Kosmidis's work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (17 papers) and Urinary Tract Infections Management (10 papers). J. Kosmidis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (17 papers) and Urinary Tract Infections Management (10 papers). J. Kosmidis collaborates with scholars based in Greece, United States and United Kingdom. J. Kosmidis's co-authors include J. M. T. Hamilton‐Miller, W. Brumfitt, G. K. Daikos, Panagiotis Gargalianos, Helen Giamarellou, T. Kordossis, C Stathakis, A. M. Geddes, George Koratzanis and Jean Beytout and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

J. Kosmidis

45 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Kosmidis Greece 17 296 294 206 151 110 47 794
G. Humbert France 20 528 1.8× 283 1.0× 242 1.2× 145 1.0× 104 0.9× 75 976
Laurel C. Preheim United States 22 244 0.8× 687 2.3× 218 1.1× 283 1.9× 163 1.5× 51 1.3k
J. L. Vildé France 17 110 0.4× 583 2.0× 128 0.6× 420 2.8× 83 0.8× 50 1.1k
Robert B. Kammer United States 10 163 0.6× 327 1.1× 95 0.5× 156 1.0× 160 1.5× 14 730
J.P. Thys Belgium 22 257 0.9× 523 1.8× 151 0.7× 307 2.0× 61 0.6× 62 1.3k
Temple W. Williams United States 20 259 0.9× 595 2.0× 94 0.5× 352 2.3× 48 0.4× 54 1.7k
Patty Fan‐Havard United States 18 130 0.4× 406 1.4× 188 0.9× 438 2.9× 78 0.7× 33 1.1k
M. Micoud France 14 96 0.3× 271 0.9× 68 0.3× 205 1.4× 41 0.4× 70 739
M. F. Kergueris France 12 208 0.7× 138 0.5× 67 0.3× 139 0.9× 42 0.4× 32 533
Jen-Hsien Wang Taiwan 12 100 0.3× 445 1.5× 225 1.1× 149 1.0× 87 0.8× 18 748

Countries citing papers authored by J. Kosmidis

Since Specialization
Citations

This map shows the geographic impact of J. Kosmidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kosmidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kosmidis more than expected).

Fields of papers citing papers by J. Kosmidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kosmidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kosmidis. The network helps show where J. Kosmidis may publish in the future.

Co-authorship network of co-authors of J. Kosmidis

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kosmidis. A scholar is included among the top collaborators of J. Kosmidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kosmidis. J. Kosmidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falagas, Matthew E., Ioannis A. Bliziotis, J. Kosmidis, & G. K. Daikos. (2010). Unusual climatic conditions and infectious diseases: observations made by Hippocrates. Enfermedades Infecciosas y Microbiología Clínica. 28(10). 716–718. 14 indexed citations
2.
Adamis, George, et al.. (2004). Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers. International Journal of Antimicrobial Agents. 23(2). 144–149. 22 indexed citations
3.
Lundgren, Jens, Simon Barton, Adriano Lazzarin, et al.. (1995). Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS. Clinical Infectious Diseases. 21(1). 106–113. 24 indexed citations
4.
Economou, E. N., et al.. (1994). Asymptomatic Bacteriuria of Pregnancy: Do Obstetricians Bother?. Journal of Chemotherapy. 6(1). 58–60. 1 indexed citations
5.
Hoepelman, A. I. M., Hans Kieft, Mabel Aoun, et al.. (1993). International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. Journal of Antimicrobial Chemotherapy. 32(suppl B). 175–186. 40 indexed citations
6.
Constantinides, C., et al.. (1990). Acute Prostatitis: Which Antibiotic to Use First. Journal of Chemotherapy. 2(4). 244–246. 8 indexed citations
7.
Beytout, Jean, et al.. (1989). Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. Journal of Antimicrobial Chemotherapy. 23(3). 433–439. 72 indexed citations
8.
Kosmidis, J., et al.. (1989). Acute, uncomplicated, lower urinary tract infections: the role of single-dose fleroxacin.. PubMed. 1(4 Suppl). 864–5. 1 indexed citations
9.
Kosmidis, J., et al.. (1988). The Value of Twice-Daily Cefotaxime in Lower Respiratory Tract Infections. Drugs. 35(Supplement 2). 214–215. 3 indexed citations
10.
Kosmidis, J., Panagiotis Gargalianos, Georgios Adamis, Dimitra Petropoulou, & Dimitrios Makris. (1988). Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 219–221. 21 indexed citations
11.
Kosmidis, J., et al.. (1988). Staphylococcal infections in hospital: the Greek experience. Journal of Hospital Infection. 11. 109–115. 14 indexed citations
12.
Daikos, G. K., et al.. (1981). Ceftazidime: therapeutic results in various infections and kinetic studies. Journal of Antimicrobial Chemotherapy. 8(suppl B). 331–337. 27 indexed citations
13.
Giamarellou, Helen, et al.. (1981). In-vitro studies with ceftazidime. Journal of Antimicrobial Chemotherapy. 8(suppl B). 73–77. 9 indexed citations
14.
Daikos, G. K., et al.. (1980). Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. Journal of Antimicrobial Chemotherapy. 6(suppl A). 255–261. 6 indexed citations
15.
Kosmidis, J., et al.. (1979). Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.. PubMed. 29(12a). 1960–2. 5 indexed citations
16.
Kosmidis, J., et al.. (1977). Cefuroxime in Renal Insufficiency: Therapeutic Results in Various Infections and Pharmacokinetics Including the Effects of Dialysis. Proceedings of the Royal Society of Medicine. 70(9_suppl). 139–143. 8 indexed citations
17.
Daikos, G. K., J. Kosmidis, J. M. T. Hamilton‐Miller, & W. Brumfitt. (1976). Amikacin in Treatment of Infections Caused by Gram-Negative Bacteria Resistant to Gentamicin and Other Aminoglycosides: Clinical and Bacteriologic Results. The Journal of Infectious Diseases. 134(Supplement 2). S286–S290. 4 indexed citations
18.
Hamilton‐Miller, J. M. T., J. Kosmidis, & W. Brumfitt. (1974). Pharmacokinetic studies with a new pivampicillin: The free base. Infection. 2(4). 193–195. 1 indexed citations
19.
Brumfitt, W., J. M. T. Hamilton‐Miller, & J. Kosmidis. (1973). Trimethoprim-Sulfamethoxazole: The Present Position. The Journal of Infectious Diseases. 128(Supplement 3). S778–S791. 33 indexed citations
20.
Papachristou, Evangelos, et al.. (1970). Clinicolaboratory Evaluation of Cephalexin, a new oral Cephalosporin. International Journal of Clinical Practice. 24(9). 379–386. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Humbert Breakdown of academic impact, for papers by Laurel C. Preheim Breakdown of academic impact, for papers by J. L. Vildé Breakdown of academic impact, for papers by Robert B. Kammer Breakdown of academic impact, for papers by J.P. Thys Breakdown of academic impact, for papers by Temple W. Williams Breakdown of academic impact, for papers by Patty Fan‐Havard Breakdown of academic impact, for papers by M. Micoud Breakdown of academic impact, for papers by M. F. Kergueris Breakdown of academic impact, for papers by Jen-Hsien Wang
Rankless by CCL
2026